Cardiovascular revascularization medicine : including molecular interventions
-
Cardiovasc Revasc Med · Feb 2021
Frailty predicts adverse outcomes in older patients undergoing transcatheter aortic valve replacement (TAVR). From the National Inpatient Sample.
We aimed to study the impact of frailty on the outcome of transcatheter aortic valve replacement (TAVR) procedures. ⋯ The HFRS can be utilized in the risk stratification of older patients undergoing TAVR.
-
Cardiovasc Revasc Med · Feb 2021
Meta AnalysisSafety and Efficacy of Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Given current evidence, the use of colchicine for the prevention of adverse cardiovascular events in patients with coronary artery disease (CAD) remains controversial. ⋯ In patients with CAD presenting with an acute coronary syndrome or stable angina, colchicine might offer no significant reduction in MACE and could potentially be harmful due to a significantly higher risk of GI-related adverse events.